Results 261 to 270 of about 7,961,527 (324)

INTAL OPHTHALMIC SOLUTION

Medical Journal of Australia, 1976
openaire   +2 more sources

Comparison of the Effects of Ophthalmic Solutions on Human Corneal Epithelial Cells Using Fluorescent Dyes

Journal of Ocular Pharmacology and Therapeutics, 2013
Manlong Xu, J. Sivak, D. McCanna
semanticscholar   +1 more source

Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS.

International journal of pharmaceutics, 2013
Jiawei Li, Hainan Zhao, C. Okeke, Lin Li, Zhidong Liu, Zhongpeng Yin, Pengwei Zhuang, Jingtong Sun, Tao Wu, Meng Wang, Nan Li, Jiaxin Pi, Qian Zhang, Rui Zhang, Li Ma, Xiaochen Pang, Zhanbiao Liu, Li Zhang, Lili Fan   +18 more
semanticscholar   +1 more source

Local toxicity of benzalkonium chloride in ophthalmic solutions following repeated applications.

Journal of Toxicological Sciences, 2013
A. Okahara, K. Kawazu
semanticscholar   +1 more source

Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses.

Carbohydrate Polymers, 2013
M. Garcia-Fernandez, N. Tabary, Bernard Martel, F. Cazaux, A. Oliva, Pablo Taboada, A. Concheiro, C. Alvarez‐Lorenzo   +7 more
semanticscholar   +1 more source

Reduced in vivo Ocular Surface Toxicity with Polyquad-Preserved Travoprost versus Benzalkonium-Preserved Travoprost or Latanoprost Ophthalmic Solutions

Ophthalmic Research, 2012
Hong Liang, F. Brignole-Baudouin, L. Riancho, C. Baudouin   +3 more
semanticscholar   +1 more source

Chemical Preservatives for Ophthalmic Solutions

American Journal of Ophthalmology, 1955
openaire   +2 more sources

Comparative In Vitro Toxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells

Current Eye Research, 2011
F. Brignole-Baudouin, L. Riancho, Hong Liang, C. Baudouin   +3 more
semanticscholar   +1 more source

Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.

American journal of ophthalmology-glaucoma, 2010
T. T. Macejko, M. Bergmann, Jon I Williams, J. Gow, P. Gomes, T. McNamara, M. Abelson   +6 more
semanticscholar   +1 more source

Proposal of a New <i>in vitro</i> Evaluation Method Using pH Changes as an Indicator to Evaluate Irritation by Ophthalmic Solutions

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2020
Hiroko Otake, Yoshikazu Shimomura, Takeshi Kotake   +2 more
exaly